Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer’s disease

被引：1

作者：

Andrew K. Evans ^{[1
]}

Heui Hye Park ^{[1
]}

Claire E. Woods ^{[1
]}

Rachel K. Lam ^{[1
]}

Daniel Ryskamp Rijsketic ^{[1
]}

Christine Xu ^{[2
]}

Emily K. Chu ^{[1
]}

Peter Ciari ^{[1
]}

Sarah Blumenfeld ^{[1
]}

Laura M. Vidano ^{[1
]}

Nay Lui Saw ^{[1
]}

Boris D. Heifets ^{[1
]}

Mehrdad Shamloo ^{[2
]}

机构：

[1] Stanford University School of Medicine,Department of Neurosurgery

[2] Stanford University School of Medicine,Department of Anesthesiology, Perioperative, and Pain Medicine

[3] Stanford University School of Medicine,Department of Psychiatry and Behavioral Sciences

来源：

Journal of Neuroinflammation | / 21卷 / 1期

关键词：

Alzheimer’s Disease; Norepinephrine; Locus coeruleus; Beta-adrenergic receptor; Beta-blocker; Neuroinflammation; iDISCO+; Amyloid beta; Microglia;

D O I：

10.1186/s12974-024-03306-1

中图分类号：

学科分类号：

摘要：

Norepinephrine (NE) modulates cognitive function, arousal, attention, and responses to novelty and stress, and it also regulates neuroinflammation. We previously demonstrated behavioral and immunomodulatory effects of beta-adrenergic pharmacology in mouse models of Alzheimer’s disease (AD). The current studies were designed to block noradrenergic signaling in 5XFAD mice through (1) chemogenetic inhibition of the locus coeruleus (LC), (2) pharmacologic blocking of β-adrenergic receptors, and (3) conditional deletion of β1- or β2-adrenergic receptors (adrb1 or adrb2) in microglia.

引用

共 50 条

[31] Transgenic mouse models of Alzheimer's disease
Janus, C
Westaway, D
PHYSIOLOGY & BEHAVIOR, 2001, 73 (05) : 873 - 886
[32] INHIBITION OF GLUTAMINYL CYCLASE TARGETING NEURODEGENERATION AND NEUROINFLAMMATION IN ALZHEIMER'S DISEASE
Demuth, Hans-Ulrich
Schilling, S.
Cynis, H.
Heiser, U.
Manhart, S.
Graubner, S.
Alexandru, A.
Jagla, W.
Lues, I.
Weber, F.
Glund, K.
NEUROBIOLOGY OF AGING, 2012, 33 : S7 - S7
[33] Neuroinflammation increases oxygen extraction in a mouse model of Alzheimer's disease
Liu, Chang
Cardenas-Rivera, Alfredo
Teitelbaum, Shayna
Birmingham, Austin
Alfadhel, Mohammed
Yaseen, Mohammad A.
ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
[34] Restoring synaptic plasticity and memory in mouse models of Alzheimer's disease by PKR inhibition
Hwang, Kyoung-Doo
Bak, Myeong Seong
Kim, Sang Jeong
Rhee, Sangmyung
Lee, Yong-Seok
MOLECULAR BRAIN, 2017, 10
[35] Restoring synaptic plasticity and memory in mouse models of Alzheimer’s disease by PKR inhibition
Kyoung-Doo Hwang
Myeong Seong Bak
Sang Jeong Kim
Sangmyung Rhee
Yong-Seok Lee
Molecular Brain, 10
[36] Matrine ameliorates cognitive deficits via inhibition of microglia mediated neuroinflammation in an Alzheimer's disease mouse model
Li, Juan
Cheng, Xiao-Yu
Yang, Hui
Li, Li
Niu, Yang
Yu, Jian-Qiang
Li, Wei-Qi
Yao, Yao
PHARMAZIE, 2020, 75 (07): : 344 - 347
[37] Matrine ameliorates cognitive deficits and neuroinflammation via inhibition of microglial activation in an Alzheimer's disease mouse model
Li, Juan
Niu, Yang
Han, Huai-qin
Li, Wei-Qi
Biswas, Sangita
Sun, Na
Li, Nan
Yao, Yao
BIOCHEMICAL PHARMACOLOGY, 2017, 139 : 132 - 133
[38] Noradrenergic dysfunction in Alzheimer's disease
Gannon, Mary
Che, Pulin
Chen, Yunjia
Jiao, Kai
Roberson, Erik D.
Wang, Qin
FRONTIERS IN NEUROSCIENCE, 2015, 9
[39] Motor impairment in Alzheimer's disease and transgenic Alzheimer's disease mouse models
Wirths, O.
Bayer, T. A.
GENES BRAIN AND BEHAVIOR, 2008, 7 : 1 - 5
[40] Aberrantly activated TAK1 links neuroinflammation and neuronal loss in Alzheimer?s disease mouse models
Sai, Kazuhito
Nakanishi, Aoi
Scofield, Kimberly M.
Tokarz, Debra A.
Linder, Keith E.
Cohen, Todd J.
Ninomiya-Tsuji, Jun
JOURNAL OF CELL SCIENCE, 2023, 136 (06)

← 1 2 3 4 5 →